Abstract
At the Drug Information Association (DIA) 49th annual meeting, for the first time regulators (Dr Francesca Cerreta, Dr Robert Temple and Dr Yasuko Asahina) from the three International Conference on Harmonization (ICH) co-sponsor regions came together in a forum to discuss their perspective on how the aging population impacts on drug development and on the design of clinical trials. In 2010, the ICH E7 Guideline (Studies in support of Special Populations: Geriatrics) was revised with the addition of a Questions and Answers document to take into account the rapidly changing world demographics. Regulators from the three ICH regions (Europe, USA and Japan) discuss here how they foresee the application of this guideline, and the impact that this might have on new drug development and clinical trial design. This article aims to summarize the discussions at the session for the benefit of a wider audience.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
International Conference on Harmonization (1993) Studies in support of special populations: Geriatrics E7. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E7/Step4/E7_Guideline.pdf. Accessed 5 May 2014
European Medicines Agency (2011) EMA geriatric medicines strategy. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E7/Step4/E7_Guideline.pdf. Accessed 5 May 2014.
International Conference on Harmonization (2010) E7 Studies in support of special populations: Geriatrics questions & answers. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E7/Q_As/E7_Q_As_step4.pdf. Accessed 5 May 2014.
Asahina Y, Sugano H, Sugiyama E, Uyama Y. Representation of older patients in clinical trials for drug approval in Japan. J Nutr Health Aging 2014;18:520–23.
Good Review Practice: Clinical Review of Investigational New Drug Applications.http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/UCM377108.pdf. Accessed 26 May 2014.
U.S. Food and Drug Administration (2011) White Paper: U.S. Food and Drug Administration (FDA) inventory of clinical trials protocols and clinical study data. http://www.fda.gov/downloads/drugs/developmentapprovalprocess/conductingcl inicaltrials/ucm309552.pdf. Accessed 5 May 2014.
European Medicines Agency (2013) Proposal for the development of a points to consider for baseline characterisation of frailty status. http://www.ema.europa.eu/docs/en_GB/document_library/Other/2013/06/WC500144373.pdf. Accessed 5 May 2014.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cerreta, F., Temple, R., Asahina, Y. et al. Regulatory activities to address the needs of older patients. J Nutr Health Aging 19, 232–233 (2015). https://doi.org/10.1007/s12603-014-0494-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-014-0494-4